Ketogenic Diet Compared With Mixed Diet in Heart Failure
Compares a low-carb ketogenic diet with a low-fat diet in adults with heart failure.
Key facts
- Who runs it
- Ohio State University
- Where
- Columbus, United StatesSee the site
- Trial code
- Registry title
- Ketogenic Diet vs Mixed Diet in Patients With Heart Failure
- Status
- Recruiting
- People taking part
- 90 people, planned
- Started
- 19 May 2023
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Ketogenic diet
- Low-fat Mixed diet
- Record updated
- 19 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 80 with heart failure with preserved pumping function who are overweight or have diabetes, pre-diabetes or metabolic syndrome. Everyone is randomly given a ketogenic diet or a low-fat diet.
- Age
- 18 to 80 years
- Sex
- Women and men can join.
- Disease stage
- Heart failure of NYHA class I to III for at least 3 months, with ejection fraction of 40% or more and abnormal or unclear diastolic function on echo or on heart catheter measurements.
- Earlier treatment
- Heart and diabetes medicines must be stable for at least 3 months. Oral diuretic dose must be stable for 1 week before randomization. Cannot be on a low-carb diet now (30-day washout needed).
- Biomarker or test result
- BMI of 25 or more, or type 2 diabetes, or pre-diabetes (fasting glucose 100 to 125 mg/dL (5.6–6.9 mmol/L) or A1C 5.7 to 6.4% (39–46 mmol/mol)), or metabolic syndrome.
Main reasons for not taking part
- Pregnant, breast-feeding, or planning pregnancy during the study
- Type 1 diabetes or a history of diabetic ketoacidosis
- Severe kidney disease (eGFR below 30)
- Implanted pacemaker, defibrillator or heart pump, or other metal implants not safe for MRI
- Heart attack or acute coronary syndrome in the last 30 days
The registry criteria, word for word
Show all 46 criteriaShow less
Other criteria
- Inclusions:
- Age ≥ 18 years old and ≤ 80 years old \& willingness to be randomized to either diet
- NYHA class I - III for at least 3 months
- Ejection fraction ≥40% by biplane 2D, or 3D echo, or CMR
- Echo findings of abnormal or indeterminant diastolic function or right heart catheterization (RHC) data: At rest: mean pulmonary capillary wedge pressure (PCWP) > 15 mmHg. pulmonary vascular resistance (PVR) < 3 Wood Units
- Stable medical therapy for at least 3 months as determined by the treating physician (no new cardiac or diabetic medications within 3 months of enrollment or during enrollment and dosage should be stable for 1 month prior to enrollment)
- Dose of oral diuretics changes allowed but must be stable for 1 week prior to randomization
- Body Mass Index (BMI) ≥ 25 or Type 2 Diabetes Mellitus or prediabetes (fasting glucose of 100 - 125 mg/dL or glycated hemoglobin (A1C) 5.7-6.4% or metabolic syndrome
- Ability to participate in exercise treadmill testing
- Ability to sign written consent; Exclusions:
- Women who are pregnant, current breast-feeding, or have intention to become pregnant while in the study
- Known allergy or sensitivity to gadolinium-based contrast agents
- Implanted pacemaker, cardioverter defibrillator, Cardiac resynchronization therapy, left ventricular assist device
- Other metallic implants/aneurysm clips that are contraindicated in MRI
- Claustrophobia
- History of severe kidney disease of estimated glomerular filtration rate (eGFR) <30 ml/kg/1.73m2
- Type I diabetes
- History of diabetic ketoacidosis
- Prior diagnosis of oxygen dependent pulmonary disease
- Body Mass Index (BMI) < 25
- Recent acute myocardial infarction or acute coronary syndrome (30 days)
- Or recent (within 30 days) or planned (within 30 days) cardiac revascularization History of left main disease, severe triple vessel disease, coronary artery bypass graft surgery
- Left ventricular ejection fraction < 50%
- Uncontrolled systemic systolic blood pressure (SBP)/diastolic blood pressure (DBP) hypertension (SBP >180 or DBP >110 mmHg)
- Severe stenotic or regurgitant valvular heart disease, expected to lead to surgery during the study period
- Persistent atrial fibrillation
- History of uncontrolled or untreated ventricular arrhythmias
- Cardiovascular diseases or treatments that increase the unpredictability of or change the subject's clinical course, independent of heart failure
- Heart transplant or listing for heart transplant
- Cardiomyopathy based on infiltrative diseases (e.g. amyloidosis), accumulation diseases (e.g. haemochromatosis, Fabry disease), muscular dystrophies, cardiomyopathy with reversible causes (e.g. stress cardiomyopathy), hypertrophic obstructive cardiomyopathy or known pericardial constriction
- Acute decompensated heart failure requiring intravenous diuretics, vasodilators, inotropic agents or mechanical support within 1 week of screening and during the screening period prior to randomization
- Hemoglobin of <9 g/dL at screening
- Major surgery (major according to the investigator's assessment) performed within 90 days prior to screening, or major scheduled elective surgery (e.g. hip replacement) within 90 days after screening
- Acute or chronic liver disease, defined by serum levels of transaminases or alkaline phosphatase more than three times the upper limit of normal at screening
- Gastrointestinal surgery or gastrointestinal disorder that might interfere with diet. Prior bariatric surgery allowed if weight-stable for past 3 months
- Any documented active or suspected malignancy or history of malignancy within 2 years prior to screening, except appropriately treated basal cell carcinoma of the skin, in situ carcinoma of the uterine cervix, or low-risk prostate cancer (subjects with pre-treatment prostate-specific antigen levels of <10 ng/mL, and biopsy Gleason scores of ≤6 and clinical stage T1c or T2a)
- Presence of any disease other than heart failure that results in a life expectancy of <1 year (in the opinion of the investigator)
- History or recurrent severe hypokalemia, potassium < 3.0 mg/dL
- Current enrollment or completion within 30 days of an investigational device or drug study
- Chronic alcohol or drug abuse or any condition that, in the investigator's opinion, will make the subject unlikely to fulfill the study requirements or complete the trial
- Any other clinical condition that might jeopardize subject safety during participation in this study or prevent the subject from adhering to the study protocol
- Unable or unwilling to follow guidelines of assigned diet group, including inability to purchase food
- Unable to participate in the comprehensive diet program, including biometric data acquisition and data entry
- The subject cannot currently be on a low-carb diet plan. 30-day washout would be required
- Patient has to have stable weight over the past 3 months (± 5% total body weight). If no weight was recorded in the past 3 months, will have 1 month lead in time for wash out
- Refusal to consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- The Ross Heart HospitalColumbus, United StatesContact: Debbie Scandling, BSTaking people
About the trial
What the trial wants to find out
This study is being done to evaluate the effects of a low carbohydrate ketogenic diet (KD) versus a low-fat diet (MD) on exercise tolerance in participants with heart failure with normal pumping function and diabetes or pre-diabetes, or metabolic syndrome, or obesity.
The 2 groups in the trial
- Ketogenic DietTreatment being tested
This arm will be provided food to induce a state of nutritional ketosis in each person as defined as blood Beta-hydroxybutyrate (3-OHB) ≥0.5 millimoles (mM), which will require most participants to consume \<50 g/day carbohydrate and 1.5g/kg reference weight protein. Fat will comprise the remaining calories with an emphasis on monounsaturated and saturated sources from whole foods.
- Low-fat mixed DietTreatment being tested
This arm will be provided food consisting of \~25% fat, and the remaining calories from carbohydrate (\~55% after accounting for protein at \~20%).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Randomized Unblinded Study of Ketogenetic Versus Mixed Diet on Exercise Tolerance in Subjects With the Metabolic Phenotype of Heart Failure With Preserved Ejection Fraction
- Plain-language title
- Ketogenic Diet Compared With Mixed Diet in Heart FailureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06081543, who can take part
- Publications
- Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review.Journal of cardiac failure, 2025
- Record updated
- 19 October 2026